Salix submits Crofelemer NDA to FDA for treatment of HIV-associated diarrhea bi13751288 Salix Pharmaceuticals, Ltd. today announced that the Company has submitted to the U.S. Food and Drug Administration (FDA) a New Drug Application (NDA) for Crofelemer for the proposed of HIV-associated diarrhea

Intravenous Remodulin Approved for the Treatment of Pulmonary Arterial Hypert bi13751288 SILVER SPRING, Md. and CHERTSEY, England , Dec. 27, 2011 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR - News) and wholly-owned subsidiary, United Therapeutics Europe, Ltd., announced today ..

Salix Pharma Submits NDA For Crofelemer For HIV-associated Diarrhea Treatment bi13751288 Salix Pharma Submits NDA For Crofelemer For HIV-associated Diarrhea ..

Salix Pharmaceuticals Announces NDA Submission for Crofelemer for the Treatme bi13751288 RALEIGH, N.C.--(BUSINESS WIRE)--Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced that the Company has submitted to the U.S. Food and Drug Administration (FDA) a New Drug Application (NDA) for Crofelemer for the proposed of HIV-associated diarrhea. By regulation, the FDA has 60 days from the date of submission to conduct a filing review to determine the application ..

Health department introduces complete treatment pack bi13751288 BONTOC, Mt. Province -- The Department of Health (DOH) introduced the Complete Pack (ComPack) program to increase patient?s access to quality essential medicine, to improve primary health care the poorest communities, and to provide complete regimens to indigent patients. The DOH ComPack program designed to reach the poorest of the poor for the of the common ..

FDA Approves EDARBYCLOR (azilsartan medoxomil and chlorthalidone) for the Tre bi13751288 DEERFIELD, Ill. and OSAKA, Japan , Dec. 20, 2011 /PRNewswire/ -- Takeda Pharmaceutical Company Limited (Takeda) and wholly-owned subsidiary, Takeda Pharmaceuticals North America, Inc., announced today ..

Soybean compounds can increase effectiveness of radiation treatment for lung bi13751288 A Wayne State University researcher has shown that compounds found soybeans can make radiation of lung cancer tumors more effective helping to preserve normal tissue

Salix submits Crofelemer NDA to FDA for treatment of HIV-associated diarrhea bi13751288 Salix Pharmaceuticals, Ltd. today announced that the Company has submitted to the U.S. Food and Drug Administration (FDA) a New Drug Application (NDA) for Crofelemer for the proposed of HIV-associated diarrhea

Salix Pharma Submits NDA For Crofelemer For HIV-associated Diarrhea Treatment bi13751288 Salix Pharma Submits NDA For Crofelemer For HIV-associated Diarrhea ..

Salix submits FDA application for Crofelemer bi13751288 Salix Pharmaceuticals Ltd. said Wednesday that submitted Crofelemer, potential for HIV-associated diarrhea, to the Food and Drug Administration for approval

Yingluck admitted to Rama 9 Hospital for diarrhea treatment bi13751288 Prime Minister Yingluck Shinawatra suffered from diarrhea and has been admitted to the Rama 9 Hospital, Government Spokesperson Thitima Chaisaeng said Tuesday

Salix Pharmaceuticals Announces NDA Submission for Crofelemer for the Treatme bi13751288 RALEIGH, N.C.--(BUSINESS WIRE)--Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced that the Company has submitted to the U.S. Food and Drug Administration (FDA) a New Drug Application (NDA) for Crofelemer for the proposed of HIV-associated diarrhea. By regulation, the FDA has 60 days from the date of submission to conduct a filing review to determine the application ..

Intravenous Remodulin Approved for the Treatment of Pulmonary Arterial Hypert bi13751288 SILVER SPRING, Md. and CHERTSEY, England , Dec. 27, 2011 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR - News) and wholly-owned subsidiary, United Therapeutics Europe, Ltd., announced today ..

Brake Installation Pad - Home